-
Mayo Clinic snags $50M gift
Rochester, Minn.-based Mayo Clinic received a $50 million gift to expand access to cancer care and clinical trials. -
Undiagnosed cancer persisted past pandemic's 1st year: 150,000 cases missed
Cancer continued to be underdiagnosed after the first year of the COVID-19 pandemic, according to a study published Sept. 6 in JAMA Network Open. -
'Patients are going to ask for it': Inside Ochsner's pharmacogenomic testing program
New Orleans-based Ochsner Health was met with some uncertainty when it launched its pharmacogenomic program in March 2022 and became one of the first health systems to standardize genomic testing. -
The path to 100% nurse satisfaction: A look at Lee Health's success with balanced patient assignments
When healthcare staffing shortages strain resources and limit care access, both clinical staff and patients feel the pain. -
National Cancer Institute proposes $11B budget for 2026
The National Cancer Institute has proposed a budget of more than $11 billion for the 2026 fiscal year. -
Mayo Clinic researchers find new melanoma risk factor
Individuals with monoclonal B-cell lymphocytosis may also have an increased risk of developing melanoma, according to a study published Sept. 4 in the Journal of Clinical Oncology. -
Mass General Brigham revamps cancer care model
Boston-based Mass General Brigham Cancer Center has unveiled plans for a more integrative cancer care model. -
FDA to require hospitals to notify women of breast density in mammograms
Starting Sept. 10, the FDA will require hospitals to notify women if their mammogram reveals they have dense breast tissue, but there's still some disagreement on what to do once the women are given this information, The Wall Street Journal reported Sept. 6. -
Cervical cancer screening self-collection kits en route to providers
Self-collection kits for cervical cancer screening have begun to ship to healthcare facilities, according to a Sept. 5 report from ABC News. -
45 cancer centers with proton therapy in the US
There are only 45 cancer centers in the U.S. that offer proton beam therapy, according to data from the National Association for Proton Therapy. -
Half of non-relapse-related deaths in lymphoma patients caused by infection: Study
Infections are the cause of more than half of all non-relapse-related deaths after chimeric antigen receptor T-cell immunotherapy for lymphoma and multiple myeloma patients, according to a study published July 8 in Nature Medicine. -
City of Hope partners with hospital in Asia
Specialists from Los Angeles-based City of Hope will now offer second-opinion services to patients at Healthway Cancer Care Hospital in the Philippines. -
10 ways to improve cancer patients' transition to skilled nursing facilities: Viewpoint
Physicians from the New York City-based Memorial Sloan Kettering Cancer Center have shared insights on how to better manage care when an oncology patient transfers from the hospital to a skilled nursing facility setting. Their guidelines, which include strategies for addressing communication barriers between care teams and documenting patient progress expectations, were shared in an editorial published Sept. 3 in JCO Oncology Practice. -
False-positive mammograms lead to fewer follow-up screenings: Study
Women are less likely to return for additional breast cancer screening after receiving a false-positive mammogram result, according to a study published Sept. 3 in the American College of Physicians' Annals of Internal Medicine. -
NIH cancer survival data: 3 things to know
Lung and bronchus cancers have the lowest five-year survival rate, according to the NIH National Cancer Institute's "Cancer Trends Progress Report." -
States with highest, lowest breast cancer screening recall rates
Minnesota has the lowest breast cancer screening recall rate, while New York's rate is about six times higher, according to CMS data. -
NIH cancer mortality data: 3 things to know
The NIH National Cancer Institute has released its annual "Cancer Trends Progress Report." -
NIH cancer incidence data: 3 things to know
The NIH National Cancer Institute has released its annual "Cancer Trends Progress Report." -
Cancer blood test concepts may be based on flawed science: WSJ
Four years ago, a study found that cancer has unique microbial signatures that would allow a blood test to diagnose cancer. But in recent months, the study has faced scrutiny for inaccurate data, The Wall Street Journal reported Aug. 30. -
2 ethnic groups see notable rise in breast cancer
Asian American and Pacific Islander women once had relatively low rates of breast cancer, but the demographic is now seeing faster-rising rates of cancer compared to other races — and experts are not sure why, CBS News reported Sep. 3.
Page 5 of 50